neurokinin b has been researched along with pd 176252 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashwood, V; Brownhill, V; Higginbottom, M; Horwell, DC; Hughes, J; Lewthwaite, RA; McKnight, AT; Pinnock, RD; Pritchard, MC; Suman-Chauhan, N; Webb, C; Williams, SC | 1 |
| Garcia, L; Jensen, RT; Leyton, J; Moody, TW | 1 |
2 other study(ies) available for neurokinin b and pd 176252
| Article | Year |
|---|---|
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist.
Topics: Animals; Gastrin-Releasing Peptide; Humans; Indoles; Kinetics; Ligands; Models, Chemical; Neurokinin B; Rats; Receptors, Bombesin; Species Specificity; Structure-Activity Relationship | 1998 |
Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells.
Topics: Animals; Binding, Competitive; Calcium; Cell Division; Clone Cells; Cytosol; Dose-Response Relationship, Drug; Indoles; Mice; Mice, Nude; Neurokinin B; Proto-Oncogene Proteins c-fos; Pyridines; Receptors, Bombesin; RNA, Messenger; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2000 |